Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin. | Dermatol Res Pract | 2023 | 36714681 | PubTator, text mining | PubMed |
| Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications. | J Cereb Blood Flow Metab | 2023 | 36704819 | PubTator, text mining | PubMed |
| Hesperidin enhances intestinal barrier function in Caco-2 cell monolayers via AMPK-mediated tight junction-related proteins. | FEBS Open Bio | 2023 | 36700348 | PubTator, text mining | PubMed |
| GRHL2-controlled gene expression networks in luminal breast cancer. | Cell Commun Signal | 2023 | 36691073 | PubTator, text mining | PubMed |
| Leaky Gut and the Ingredients That Help Treat It: A Review. | Molecules | 2023 | 36677677 | PubTator, text mining | PubMed |
| C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. | Int J Mol Sci | 2023 | 36675048 | PubTator, text mining | PubMed |
| Immunohistochemistry for Claudin-4 and BAP1 in the Differential Diagnosis between Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma. | Diagnostics (Basel) | 2023 | 36673059 | PubTator, text mining | PubMed |
| Role of Ferroptosis in Regulating the Epithelial-Mesenchymal Transition in Pulmonary Fibrosis. | Biomedicines | 2023 | 36672671 | PubTator, text mining | PubMed |
| Tight Junction Protein Signaling and Cancer Biology. | Cells | 2023 | 36672179 | PubTator, text mining | PubMed |
| Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M). | Cells | 2023 | 36672170 | PubTator, text mining | PubMed |
| CDT of Clostridioides difficile Induces MLC-Dependent Intestinal Barrier Dysfunction in HT-29/B6 Epithelial Cell Monolayers. | Toxins (Basel) | 2023 | 36668874 | PubTator, text mining | PubMed |
| Current understanding of the intratumoral microbiome in various tumors. | Cell Rep Med | 2023 | 36652905 | PubTator, text mining | PubMed |
| Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer. | Adv Sci (Weinh) | 2023 | 36638276 | PubTator, text mining | PubMed |
| Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome. | Mol Med | 2023 | 36635623 | PubTator, text mining | PubMed |
| Cord blood epigenome-wide meta-analysis in six European-based child cohorts identifies signatures linked to rapid weight growth. | BMC Med | 2023 | 36627699 | PubTator, text mining | PubMed |
| Fermentation Supernatant of Elderly Feces with Inulin and Partially Hydrolyzed Guar Gum Maintains the Barrier of Inflammation-Induced Caco-2/HT29-MTX-E12 Co-Cultured Cells. | J Agric Food Chem | 2023 | 36622307 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. | Int J Mol Sci | 2023 | 36614326 | PubTator, text mining | PubMed |
| Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 36614243 | PubTator, text mining | PubMed |
| Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report. | BMC Med Genomics | 2023 | 36604730 | PubTator, text mining | PubMed |
| PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets. | Toxicol Lett | 2023 | 36596350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=31